Focusing on the results for the fiscal year ending July 2026 and the forecast for July 2027, the document outlines a full-scale rollout in the skin care domain centered on Skin for Longevity, expansion of the Recovery Wear business, strengthened sales channels, and group synergies for mid- to long-term growth. Although revenue is expected to be flat to slightly down year over year, brand investment and new product launches are planned to continue toward 2027.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4934","jir_company_name":"Premier Anti-Aging Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4934-20260914-05.pdf","jir_short_summary":"Focusing on the results for the fiscal year ending July 2026 and the forecast for July 2027, the document outlines a full-scale rollout in the skin care domain centered on Skin for Longevity, expansion of the Recovery Wear business, strengthened sales channels, and group synergies for mid- to long-term growth. Although revenue is expected to be flat to slightly down year over year, brand investment and new product launches are planned to continue toward 2027.","jir_summary":"### Section Heading\nFor the fiscal year ended July 2026, the plan is to balance Recovery business growth with new initiatives in the anti-aging business. Revenue is expected to be flat or slightly down versus the previous year, but will push horizontal deployment of brand development know-how such as Duo and Canadel, and full-scale expansion of the Skin for Longevity-centric skincare domain.\n\n### Section 2 Heading\nFor the fiscal year ending July 2027, while the sales forecast assumes level with the prior year, operating income is expected to decline significantly due to stronger advertising and promotional investments. However, by maximizing LTV, CRM initiatives, and new product launches, the company aims to build a long-term growth foundation.","jir_financial_highlights":"Net sales: 13,883 million yen (FY2026 Actual)\nOperating income: 494 million yen (FY2026 Actual)\nNet income attributable to owners of the parent: 364 million yen (FY2026 Actual)","jir_category":"","jir_hashtags":"#PremierAntiAging, #GrowthStrategy, #SkinforLongevity, #RecoveryWear, #ESG Sustainability","jir_key_figures":"FY2026 Net sales 13,883 million yen\nFY2026 Operating income 494 million yen\nFY2026 Net income attributable to owners of the parent 364 million yen","jir_meta_title":"\u3010Premier Anti-Aging\u3011Explanation Material on Business Plan and Growth Strategy\uff5cResults for FY2026 and Outlook for FY2027","jir_meta_description":"Explanation of Premier Anti-Aging's business plan and growth strategy. Long-term growth through full-scale Skin for Longevity-driven skincare expansion, Recovery Wear expansion, stronger distribution channels, and group synergy.","jir_og_title":"\u3010Premier Anti-Aging\u3011Explanation Material on Business Plan and Growth Strategy","jir_og_description":"Growth strategy outlining product development and store expansion centered on Skin for Longevity, expansion of Recovery Wear, and CRM enhancement to improve quality of life.","jir_og_image_url":"\/assets\/og\/company-business_update.jpg","jir_chart_data_collection":"[]","ir_related_company":59723,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-113812","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n